Poster Presentations at the Upcoming Society for Neuroscience 2014 Meeting Feature iCell Neurons & DopaNeurons.
See the Abstracts...
With 100+ employees and >800 patents, CDI manufactures human iPS cell-derived cell types with the quality, quantity, and purity required for basic life science and drug discovery research.
Aug 28, 2014
Cellular Dynamics Granted Patent for Automated Production of Cells
Jul 9, 2014
Cellular Dynamics Claims Patents on Making Stem Cells from Blood
Jun 30, 2014
Banking on iPSCs
May 1, 2014
Measuring Pharmaco-influences on Neural Networks
Apr 30, 2014
Cellular Dynamics Press Release
Cellular Dynamics Announces Launch of iCell® DopaNeurons, Neural Floor Plate-derived Midbrain Dopaminergic Neurons
Feb 28, 2014
Reluctant Star of Stem Cell Research
iCell Skeletal Myoblasts cells can be used to understand and modulate basic cellular developmental processes, implemented into targeted and phenotypic screens for molecular therapies, and be deployed as a platform to develop cellular therapies for regenerative medicine.
Join the scientists switching to human iPSC-derived cells to advance research in toxicity, discovery, and regenerative medicine. See their stories: